Table 2:
Minimally adjusted and fully adjusted estimates of intervention effects for pre-specified study outcomes.
Arm | Proportion | Risk Ratio (95% CI) | Risk Difference (95% CI) | ||
---|---|---|---|---|---|
Minimally Adjusted | Fully Adjusted | Minimally Adjusted | Fully Adjusted | ||
Primary – ACTs sold to malaria test-positive clients | |||||
Control | 49/558 (8.8%) | — | — | — | — |
Intervention | 49/626 (7.8%) | 0.85 (0.34, 2.16) | 0.79 (0.27, 2.33) | −0.01 (−0.09, 0.07) | −0.02 (−0.10, 0.07) |
Secondary 1 -- Suspected malaria cases that receive a mRDT (testing uptake) | |||||
Control | 226/928 (24%) | — | — | — | — |
Intervention | 217/958 (23%) | 0.92 (0.47, 1.78) | 0.95 (0.50, 1.81) | −0.01 (−0.20, 0.18) | 0.01 (−0.18, 0.20) |
Secondary 2 – Malaria tested clients whose treatment adhered to test results | |||||
Control | 167/226 (74%) | — | — | — | — |
Intervention | 118/217 (54%) | 0.76 (0.36, 1.62) | 0.77 (0.36, 1.64) | −0.17 (−0.36, 0.01) | −0.17 (−0.37, 0.03) |
Secondary 3 – Suspected malaria cases that are managed appropriately | |||||
Control | 167/928 (18%) | — | — | — | — |
Intervention | 118/958 (12%) | 0.67 (0.33, 1.33) | 0.66 (0.33, 1.31) | −0.05 (−0.19, 0.10) | −0.06 (−0.24, 0.11) |
Secondary 4 – Untested clients taking ACT | |||||
Control | 462/836 (55%) | — | — | — | — |
Intervention | 498/827 (60%) | 1.09 (0.62, 1.90) | 1.02 (0.60, 1.74) | 0.05 (−0.03, 0.12) | 0.01 (−0.08, 0.09) |